Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
- Author
- JIE HONG1 ; YIFEI ZHANG1 ; DAJIN ZOU6 ; DAWANG WANG7 ; HONG LI8 ; CHAO LIU9 ; GUOTING WU10 ; JIE SHEN11 ; DALONG ZHU12 ; WEIQING WANG1 ; WEIFENG SHEN1 ; GUANG NING1 ; SHENGHAN LAI2 ; ANKANG LV1 ; QING SU3 ; YAN DONG3 ; ZHIGUANG ZHOU4 ; WEILI TANG4 ; JIAJUN ZHAO5 ; LIANQUN CUI5
[1] Rui-jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
[2] Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
[3] Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
[4] The Second Xiangya Hospital of Central South University, Changsha, China
[5] Shandong Provincial Hospital, Shandong University, Jinan, China
[6] Chang Hai Hospital, Second Military Medical University, Shanghai, China
[7] The First Affiliated Hospital of Wenzhou Medical College, Zhejiang Province, China
[8] Sir Run Run Shao Hospital, Zhejiang Province, China
[9] Jiangsu Province Hospital, Jiangsu Provnce, China
[10] Shanghai Ten's People's Hospital of Tongji University, Shanghai, China
[11] Nanfang Hospital, Guangdong Province, China
[12] Nanjin Drum Tower Hospital, Jiangsu Province, China
THE SPREAD-DIMCAD INVESTIGATORS - Source
Diabetes care. 2013, Vol 36, Num 5, pp 1304-1311, 8 p ; ref : 32 ref
- CODEN
- DICAD2
- ISSN
- 0149-5992
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- American Diabetes Association, Alexandria, VA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Cardiopathie coronaire Diabète de type 2 Endocrinologie Etude comparative Glipizide Homme Hypoglycémiant Malade Maladie métabolique Metformine Nutrition Pathologie de l'appareil circulatoire Pronostic Biguanides Endocrinopathie Sulfamides Sulfonylurées
- Keyword (en)
- Coronary heart disease Type 2 diabetes Endocrinology Comparative study Glipizide Human Hypoglycemic agent Patient Metabolic diseases Metformin Nutrition Cardiovascular disease Prognosis Biguanides Endocrinopathy Sulfonamides Sulfonylureas
- Keyword (es)
- Cardiopatía coronaria Diabetes de tipo 2 Endocrinología Estudio comparativo Glipizida Hombre Hipoglicemiante Enfermo Metabolismo patología Metformina Nutrición Aparato circulatorio patología Pronóstico Biguanidas Endocrinopatía Sulfamidas Sulfonilureas
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01A Etiopathogenesis. Screening. Investigations. Target tissue resistance
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B30 Public health. Hygiene-occupational medicine / 002B30A Public health. Hygiene / 002B30A11 Miscellaneous
- Discipline
- Endocrinopathies Metabolic diseases Public health. Hygiene-occupational medicine
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27282783
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.2337/dc12-0719 
https://dx.doi.org/10.2337/dc12-0719
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/dc12-0719\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1304\";s:8:\"\u0000*\u0000epage\";s:4:\"1311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"JIE HONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YIFEI ZHANG\";i:1;s:9:\"DAJIN ZOU\";i:2;s:11:\"DAWANG WANG\";i:3;s:7:\"HONG LI\";i:4;s:8:\"CHAO LIU\";i:5;s:10:\"GUOTING WU\";i:6;s:8:\"JIE SHEN\";i:7;s:10:\"DALONG ZHU\";i:8;s:12:\"WEIQING WANG\";i:9;s:12:\"WEIFENG SHEN\";i:10;s:10:\"GUANG NING\";i:11;s:12:\"SHENGHAN LAI\";i:12;s:9:\"ANKANG LV\";i:13;s:7:\"QING SU\";i:14;s:8:\"YAN DONG\";i:15;s:13:\"ZHIGUANG ZHOU\";i:16;s:10:\"WEILI TANG\";i:17;s:11:\"JIAJUN ZHAO\";i:18;s:11:\"LIANQUN CUI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/dc12-0719\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1304\";s:8:\"\u0000*\u0000epage\";s:4:\"1311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"JIE HONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YIFEI ZHANG\";i:1;s:9:\"DAJIN ZOU\";i:2;s:11:\"DAWANG WANG\";i:3;s:7:\"HONG LI\";i:4;s:8:\"CHAO LIU\";i:5;s:10:\"GUOTING WU\";i:6;s:8:\"JIE SHEN\";i:7;s:10:\"DALONG ZHU\";i:8;s:12:\"WEIQING WANG\";i:9;s:12:\"WEIFENG SHEN\";i:10;s:10:\"GUANG NING\";i:11;s:12:\"SHENGHAN LAI\";i:12;s:9:\"ANKANG LV\";i:13;s:7:\"QING SU\";i:14;s:8:\"YAN DONG\";i:15;s:13:\"ZHIGUANG ZHOU\";i:16;s:10:\"WEILI TANG\";i:17;s:11:\"JIAJUN ZHAO\";i:18;s:11:\"LIANQUN CUI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/dc12-0719\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/dc12-0719\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1304\";s:8:\"\u0000*\u0000epage\";s:4:\"1311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"JIE HONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YIFEI ZHANG\";i:1;s:9:\"DAJIN ZOU\";i:2;s:11:\"DAWANG WANG\";i:3;s:7:\"HONG LI\";i:4;s:8:\"CHAO LIU\";i:5;s:10:\"GUOTING WU\";i:6;s:8:\"JIE SHEN\";i:7;s:10:\"DALONG ZHU\";i:8;s:12:\"WEIQING WANG\";i:9;s:12:\"WEIFENG SHEN\";i:10;s:10:\"GUANG NING\";i:11;s:12:\"SHENGHAN LAI\";i:12;s:9:\"ANKANG LV\";i:13;s:7:\"QING SU\";i:14;s:8:\"YAN DONG\";i:15;s:13:\"ZHIGUANG ZHOU\";i:16;s:10:\"WEILI TANG\";i:17;s:11:\"JIAJUN ZHAO\";i:18;s:11:\"LIANQUN CUI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/dc12-0719\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1304\";s:8:\"\u0000*\u0000epage\";s:4:\"1311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"JIE HONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YIFEI ZHANG\";i:1;s:9:\"DAJIN ZOU\";i:2;s:11:\"DAWANG WANG\";i:3;s:7:\"HONG LI\";i:4;s:8:\"CHAO LIU\";i:5;s:10:\"GUOTING WU\";i:6;s:8:\"JIE SHEN\";i:7;s:10:\"DALONG ZHU\";i:8;s:12:\"WEIQING WANG\";i:9;s:12:\"WEIFENG SHEN\";i:10;s:10:\"GUANG NING\";i:11;s:12:\"SHENGHAN LAI\";i:12;s:9:\"ANKANG LV\";i:13;s:7:\"QING SU\";i:14;s:8:\"YAN DONG\";i:15;s:13:\"ZHIGUANG ZHOU\";i:16;s:10:\"WEILI TANG\";i:17;s:11:\"JIAJUN ZHAO\";i:18;s:11:\"LIANQUN CUI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/dc12-0719\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1304\";s:8:\"\u0000*\u0000epage\";s:4:\"1311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"JIE HONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YIFEI ZHANG\";i:1;s:9:\"DAJIN ZOU\";i:2;s:11:\"DAWANG WANG\";i:3;s:7:\"HONG LI\";i:4;s:8:\"CHAO LIU\";i:5;s:10:\"GUOTING WU\";i:6;s:8:\"JIE SHEN\";i:7;s:10:\"DALONG ZHU\";i:8;s:12:\"WEIQING WANG\";i:9;s:12:\"WEIFENG SHEN\";i:10;s:10:\"GUANG NING\";i:11;s:12:\"SHENGHAN LAI\";i:12;s:9:\"ANKANG LV\";i:13;s:7:\"QING SU\";i:14;s:8:\"YAN DONG\";i:15;s:13:\"ZHIGUANG ZHOU\";i:16;s:10:\"WEILI TANG\";i:17;s:11:\"JIAJUN ZHAO\";i:18;s:11:\"LIANQUN CUI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
